Here's what the EpiPen maker says about why it won't just cut the drug's price (MYL)

The pharmaceutical company in hot water over the price of the EpiPen just answered a major question on everyone's minds. 
Why doesn't it just cut the price?
The EpiPen, a device used in emergencies to treat severe allergic reactions, costs 500% more than it did when Mylan acquired it in 2007.
To fend off public outrage over the EpiPen's cost, Mylan has done anything but cut the list price of the drug, which is $600 for a two pack.
It has raised its copay-coupon system t